Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Brem

Showing results (31-40 of 135) with videos related to

Pageof 14
Sort By:
Expert Opinion on Drug Delivery|June 12, 2013
Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divideAnn-Marie Chacko, Chunsheng Li, Daniel A Pryma, et al.
Neurosurgery|July 28, 2021
Withdrawn as duplicate: Commentary: "Zooming in" on Glioblastoma: Understanding Tumor Heterogeneity and its Clinical Implications in the Era of Single-Cell Ribonucleic Acid SequencingAlfredo Lucas, James H Eberwine, Stephen J Bagley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 22, 2008
Guidelines for the initial management of metastatic brain tumors: role of surgery, radiosurgery, and radiation therapyMatthew G Ewend, David E Morris, Lisa A Carey, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 23, 2008
Relationship of gliomas to the ventricular wallsKaveh Barami, Andrew E Sloan, Amyn Rojiani, et al.
Molecular Cancer Research : MCR|January 16, 2019
An Integrated Stress Response Agent that Modulates DR5-Dependent TRAIL Synergy Reduces Patient-Derived Glioma Stem Cell ViabilitySaad Sheikh, Deeksha Saxena, Xiaobing Tian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
In vitro drug response and molecular markers associated with drug resistance in malignant gliomasJohn P Fruehauf, Henry Brem, Steven Brem, et al.
Cancer|September 17, 2013
Preservation of neurocognitive function and local control of 1 to 3 brain metastases treated with surgery and carmustine wafersSteven Brem, Christina A Meyers, Gary Palmer, et al.
Neurosurgery|July 31, 2021
Commentary: "Zooming in" on Glioblastoma: Understanding Tumor Heterogeneity and Its Clinical Implications in the Era of Single-Cell Ribonucleic Acid SequencingAlfredo Lucas, James H Eberwine, Stephen J Bagley, et al.
Scientific Reports|January 18, 2023
Artificial intelligence-based locoregional markers of brain peritumoral microenvironmentZahra Riahi Samani, Drew Parker, Hamed Akbari, et al.
Cureus|June 21, 2019
Evaluating the Association Between the Extent of Resection and Survival in GliosarcomaFahad I Ahmed, Kalil G Abdullah, Joseph Durgin, et al.
Pageof 14

Showing results (31-40 of 135) with videos related to

Sort By:
Pageof 14
Expert Opinion on Drug Delivery|June 12, 2013
Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divideAnn-Marie Chacko, Chunsheng Li, Daniel A Pryma, et al.
Neurosurgery|July 28, 2021
Withdrawn as duplicate: Commentary: "Zooming in" on Glioblastoma: Understanding Tumor Heterogeneity and its Clinical Implications in the Era of Single-Cell Ribonucleic Acid SequencingAlfredo Lucas, James H Eberwine, Stephen J Bagley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 22, 2008
Guidelines for the initial management of metastatic brain tumors: role of surgery, radiosurgery, and radiation therapyMatthew G Ewend, David E Morris, Lisa A Carey, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 23, 2008
Relationship of gliomas to the ventricular wallsKaveh Barami, Andrew E Sloan, Amyn Rojiani, et al.
Molecular Cancer Research : MCR|January 16, 2019
An Integrated Stress Response Agent that Modulates DR5-Dependent TRAIL Synergy Reduces Patient-Derived Glioma Stem Cell ViabilitySaad Sheikh, Deeksha Saxena, Xiaobing Tian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
In vitro drug response and molecular markers associated with drug resistance in malignant gliomasJohn P Fruehauf, Henry Brem, Steven Brem, et al.
Cancer|September 17, 2013
Preservation of neurocognitive function and local control of 1 to 3 brain metastases treated with surgery and carmustine wafersSteven Brem, Christina A Meyers, Gary Palmer, et al.
Neurosurgery|July 31, 2021
Commentary: "Zooming in" on Glioblastoma: Understanding Tumor Heterogeneity and Its Clinical Implications in the Era of Single-Cell Ribonucleic Acid SequencingAlfredo Lucas, James H Eberwine, Stephen J Bagley, et al.
Scientific Reports|January 18, 2023
Artificial intelligence-based locoregional markers of brain peritumoral microenvironmentZahra Riahi Samani, Drew Parker, Hamed Akbari, et al.
Cureus|June 21, 2019
Evaluating the Association Between the Extent of Resection and Survival in GliosarcomaFahad I Ahmed, Kalil G Abdullah, Joseph Durgin, et al.
Pageof 14